Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2004Canadian Journal of GastroenterologyOpen Access

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRemo PanaccioneSemmelweis UniversityRFRichard N. FedorakSemmelweis UniversityGAGuy Anmais

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Panaccione et al. (2004) studied this question.

synapsesocial.com/papers/6a81550c407ce5842fa8d47ehttps://doi.org/10.1155/2004/670161
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease2003 · 2,028 citations
  2. 2Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFα antibodies (infliximab)2003 · 43 citations
  3. 3Infliximab Treatment for Crohn's Disease: One-Year Experience in a Dutch Academic Hospital2002 · 63 citations